MedTrace Logo

Comparison of Staples Versus Prolene Suture for Skin Closure at Cesarean Delivery

NCT01509950 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-03-04

Study results available
· View outcomes & findings →

Summary

Currently different materials are used to close the skin after a cesarean delivery, including absorbable suture, non-absorbable suture and staples. It is not known what is the best choice of material to close the skin after a cesarean section, but commonly staples or dissolvable suture is used. Recently plastic surgeons have found that non-dissolvable suture may have a better cosmetic outcome than staples. The investigators hope to learn if there is a difference in pain both at suture/staple removal and 6 weeks postoperatively between Prolene suture, Absorbable suture (monocryl or vicryl) or staples. The investigators also plan to look for differences in wound complications and patient satisfaction, as well as operating and removal times. This knowledge will be important in helping practitioners choose the closure technique at cesarean delivery.

Conditions

  • Pregnancy
  • Cesarean Section

Interventions

PROCEDURE

Staples

Staples for closure of cesarean section skin incision

PROCEDURE

Prolene non-absorbable sutures

Prolene non-absorbable sutures for closure of cesarean skin incision

PROCEDURE

Absorbable Sutures

Absorbable sutures for closure of cesarean skin incision

Sponsors & Collaborators

Principal Investigators

  • Natali Aziz, MD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-05-04
Completion
2013-05-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01509950 on ClinicalTrials.gov